ALUR Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 0.53%, SMA50 -13.23%, SMA200 -40.28%). The stock’s 14-day RSI is 47.82 (neutral), while the ATR of 0.24 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -70.57% below its high and over 29.47% above its low. Average 10-day trading volume of 21.33 million shares is significantly above the 3-month average of 2.54 million, indicating heightened recent market interest.

Allurion Technologies Inc. generated EPS of -$7.33 over the past year. Five-year average earnings growth is -618.79%. Wall Street analysts project EPS growth of 52.56% annually over the next five years. Analyst sentiment is neutral. Analyst rating data shows there are 0 Strong Buy ratings, 2 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $16.00 to $2.50. The high target offers 1200.81% upside. The low target suggests 103.25% downside. The mean target is $5.30. This offers 330.89% upside. Allurion Technologies Inc. earnings surprise history is frequent misses against expectations. The quarter that ended November 12, 2025, missed forecasts by -9.23%. The prior quarter beat by -12.31%. Over the last six quarters, Apple has recorded several small beats. These include -104.17% in August 13, 2024.

Allurion Technologies Inc. has 12.28 million shares outstanding. The public float is 4.59 million shares, elevated short interest at 4.80% of float. This equals 442.08 thousand shares. The short ratio is 4.19 days. Institutional investors hold 76.99% of the float. Insiders own 8.45%. Over the past six months, insider transactions show net selling. They sold 3.21 thousand shares across 2 transactions.

Allurion Technologies Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.25. This means the shares are trading below this model’s fair value.

Allurion Technologies Inc. (NYSE:ALUR) closed at $1.23 USD, losing -$0.13 (-9.56%) from the previous close of $1.36. The stock is currently mid-range between its 52-week high and low $0.95 and $4.18. With a market capitalization of about $9.55 million, Allurion Technologies Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.47). Key stats such as the average daily volume over the past year has been around 98.32 thousand shares, trading with heavier-than-usual volume. Headquartered in Natick, MA, Allurion Technologies Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Shantanu K. Gaur, the company employs approximately 134 people and listed since March 29, 2021. Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight.

Allurion Technologies Inc. trades at a P/E ratio of -2.3, slightly below the S&P 500 average, with a price-to-sales ratio of 0.58 and a price-to-book ratio of -1.2 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.27, also above market averages.

Our AI price prediction model suggests that Allurion Technologies Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -15.45%, with price expected at $1.04 by March 11, 2026, within a range of $0.83 to $1.24 3-Month Outlook: Projected rise of 209.76%, reaching $3.81 by May 25, 2026, with a range of $3.47 to $4.17. 1-Year Outlook: Projected loss of -98.37%, with price at $0.02 by February 25, 2027, within a range of $0.00 to $2.13.

Allurion Technologies Inc. (NYSE:ALUR) shares are up 30.08% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Allurion Technologies Inc. trading at a premium to the broader market with a P/E of -2.3. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $4.43, suggesting 260.16% upside. Our AI forecast model points to short-term weakness (-15.45% over two weeks), a medium-term rise (209.76% over three months), and a longer-term loss (-98.37% over one year), with expected trading ranges indicating moderate volatility.